Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJDementia
    • VJRegenmed
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    MDS 2023
    EAN 2023
    AHS 2023
    CMSC 2023
    ESOC 2023
    AAN 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

intracranial hemorrhage

Prevention of VTE in patients with hemorrhagic stroke 5:55
Prevention of VTE in patients with hemorrhagic stroke
Senta Frol • 30 Mar 2023
SOP for idarucizumab application in stroke patients taking dabigatran 5:40
SOP for idarucizumab application in stroke patients taking dabigatran
Senta Frol • 30 Mar 2023
Key considerations for conducting clinical trials in surgical interventions for ICH 2:45
Key considerations for conducting clinical trials in surgical interventions for ICH
Shahid Nimjee • 25 Oct 2022
Blood-brain barrier disruption increases the risk of hemorrhagic transformation in ischemic stroke 1:19
Blood-brain barrier disruption increases the risk of hemorrhagic transformation in ischemic stroke
Francesco Arba • 4 May 2022
Targeting blood pressure to reduce hemorrhagic risk after endovascular therapy 1:33
Targeting blood pressure to reduce hemorrhagic risk after endovascular therapy
Mikael Mazighi • 9 May 2022
ACTIMIS: Glenzocimab add-on therapy reduces hemorrhage and mortality in ischemic stroke 4:07
ACTIMIS: Glenzocimab add-on therapy reduces hemorrhage and mortality in ischemic stroke
Mikael Mazighi • 9 May 2022
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy